Medical Properties Trust (MPW) Stake Increased by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. lifted its position in shares of Medical Properties Trust (NYSE:MPW) by 2.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 350,326 shares of the real estate investment trust’s stock after acquiring an additional 9,810 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.10% of Medical Properties Trust worth $4,554,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Pegasus Asset Management Inc. increased its position in Medical Properties Trust by 23.7% during the 1st quarter. Pegasus Asset Management Inc. now owns 94,485 shares of the real estate investment trust’s stock worth $1,228,000 after purchasing an additional 18,085 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in Medical Properties Trust by 9.7% during the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 57,036 shares of the real estate investment trust’s stock worth $741,000 after purchasing an additional 5,041 shares in the last quarter. Dupont Capital Management Corp increased its position in Medical Properties Trust by 7.7% during the 1st quarter. Dupont Capital Management Corp now owns 295,302 shares of the real estate investment trust’s stock worth $3,839,000 after purchasing an additional 21,189 shares in the last quarter. Daiwa Securities Group Inc. increased its position in Medical Properties Trust by 17.3% during the 1st quarter. Daiwa Securities Group Inc. now owns 46,900 shares of the real estate investment trust’s stock worth $610,000 after purchasing an additional 6,900 shares in the last quarter. Finally, Global X Management Co. LLC increased its position in Medical Properties Trust by 30.9% during the 1st quarter. Global X Management Co. LLC now owns 949,913 shares of the real estate investment trust’s stock worth $12,349,000 after purchasing an additional 224,222 shares in the last quarter. Institutional investors and hedge funds own 80.15% of the company’s stock.

Shares of NYSE MPW opened at $13.08 on Friday. The company has a quick ratio of 2.04, a current ratio of 2.04 and a debt-to-equity ratio of 1.27. Medical Properties Trust has a 52-week low of $13.15 and a 52-week high of $13.31. The company has a market capitalization of $4.82 billion, a price-to-earnings ratio of 9.58, a price-to-earnings-growth ratio of 2.50 and a beta of 0.69.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings results on Thursday, May 3rd. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.36 by ($0.11). Medical Properties Trust had a net margin of 41.47% and a return on equity of 8.14%. The business had revenue of $205.05 million during the quarter, compared to analyst estimates of $204.70 million. During the same quarter last year, the company posted $0.33 earnings per share. The company’s revenue was up 31.1% compared to the same quarter last year. research analysts expect that Medical Properties Trust will post 1.42 earnings per share for the current year.

In other Medical Properties Trust news, Chairman Edward K. Aldag, Jr. sold 116,216 shares of the company’s stock in a transaction that occurred on Tuesday, March 27th. The shares were sold at an average price of $12.56, for a total value of $1,459,672.96. Following the completion of the transaction, the chairman now directly owns 1,759,620 shares in the company, valued at approximately $22,100,827.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.00% of the company’s stock.

MPW has been the subject of a number of research analyst reports. Zacks Investment Research upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Wednesday, May 9th. ValuEngine cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Deutsche Bank lowered their price objective on shares of Medical Properties Trust from $13.50 to $13.00 and set a “hold” rating for the company in a research report on Monday, March 19th. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Medical Properties Trust currently has an average rating of “Hold” and an average price target of $14.28.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply